Dachaigh › Lupus › Texas › Houston
Sgrùdaidhean clionaigeach Lupus ann an Houston, TX
Tha 13 sgrùdaidhean airson Lupus a’ lorg phàirtichean aig làraichean ann agus timcheall air Houston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
A’ fastadhÌre 3
- Sl0044 50696, Houston
- Sl0044 50723, Houston
- Sl0044 50738, Bellaire · 7 mìle air falbh
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
A’ fastadhÌre 2
- Prolato Clinical Research Center, Houston
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
A’ fastadhÌre 2
- The University of Texas Health Science Center at Houston, Houston
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
A’ fastadhÌre 3
- Novel Research LLC, Bellaire · 7 mìle air falbh
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
A’ fastadhÌre 3
- Research Site, Houston
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
A’ fastadhÌre 3
- Research Site, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
A’ fastadhÌre 1
- UT MD Anderson Cancer Center, Houston
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
A’ fastadhÌre 1
- Baylor College of Medicine, Houston
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
A’ fastadhÌre 3
- Accurate Clinical Research, Humble · 17 mìle air falbh
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
A’ fastadhÌre 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
A’ fastadhÌre 3
- Novel Research, LLC., Houston
- Northwest Houston Arthritis, Houston
- Rheumatology Care Center, PLLC, Bellaire · 7 mìle air falbh
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
A’ fastadhSgrùdadh amharc
- M D Anderson Cancer Center, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
A’ fastadhÌre 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
Sgrùdaidhean Lupus ann am bailtean eile
- New York City, NY18 sgrùdaidhean
- Durham, NC12 sgrùdaidhean
- Washington, DC10 sgrùdaidhean
- Miami, FL10 sgrùdaidhean
- Tampa, FL9 sgrùdaidhean
- Philadelphia, PA9 sgrùdaidhean
- Clearwater, FL8 sgrùdaidhean
- Santa Monica, CA8 sgrùdaidhean
- Oklahoma City, OK8 sgrùdaidhean
- Boston, MA8 sgrùdaidhean
- Los Angeles, CA8 sgrùdaidhean
- Chicago, IL8 sgrùdaidhean
Sgrùdaidhean eile ann an Houston
- Aillse Sgamhain Neo-chealla-beag145 sgrùdaidhean
- Aillse a' bhroilleach126 sgrùdaidhean
- Aillse (gach seòrsa)121 sgrùdaidhean
- Ailse metastatach104 sgrùdaidhean
- Aillse colorectal102 sgrùdaidhean
- Cancer Ovarian89 sgrùdaidhean
- Leukemia myeloid geur85 sgrùdaidhean
- Ailseachadh nan Sgamhan78 sgrùdaidhean
- Aillse Prostata76 sgrùdaidhean
- Ailse Endometrial68 sgrùdaidhean
- Cancer Pancreatic61 sgrùdaidhean
- Melanoma59 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.